Capra Sphere’s Post

Pharmaceutical exports from Pakistan have experienced remarkable growth, recording a 31.11% increase in the first quarter of the financial year 2024-25 compared to the same period last year. From July to September 2024, the exports reached $105.936 million, a substantial rise from $80.796 million during the same months in 2023, according to the Pakistan Bureau of Statistics (PBS). In September 2024, the sector witnessed a 61.55% surge year-on-year, with exports hitting $43.607 million, compared to $26.992 million in September 2023. Additionally, there was a 53.78% increase month-on-month from $28.357 million in August 2024. This growth reflects the expanding capabilities and competitiveness of Pakistan's pharmaceutical industry on the global stage. #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation

🌍 Remarkable Growth in Pakistan's Pharmaceutical Exports! 🌍 Pakistan's pharmaceutical industry continues to make impressive strides on the global stage, achieving a 31.11% increase in exports in the first quarter of FY 2024-25 compared to last year. According to the Pakistan Bureau of Statistics (PBS), exports climbed from $80.796 million in July–September 2023 to an impressive $105.936 million during the same period this year. 📈 September 2024 was a standout month, with exports surging 61.55% year-on-year to reach $43.607 million, up from $26.992 million in September 2023. Moreover, the sector saw a 53.78% month-on-month increase from $28.357 million in August. This consistent growth underscores the enhanced capabilities and global competitiveness of Pakistan’s pharmaceutical sector, driven by quality production, innovation, and strong market positioning. #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation

Pakistan's pharmaceutical exports have surged by 31% in the first three months of the current fiscal year, reaching $105.9 million, according to recent trade data. This significant growth highlights the expanding global demand for Pakistani pharmaceuticals, as well as the industry's focus on quality and compliance with international standards. Key export markets include Asia, Africa, and the Middle East, where demand for affordable, quality healthcare products is on the rise. This increase also reflects Pakistan's strategic investments in pharmaceutical production, quality control, and innovation, which have bolstered the country's standing in the global healthcare sector. The government’s efforts to support exporters with incentives and streamline regulatory processes have played a pivotal role in this upward trend, positioning Pakistan's pharmaceutical sector as a growing economic asset. Visit https://lnkd.in/dYepVRg8 to know more about us #PakistanPharmaceuticals #ExportGrowth #Healthcare #GlobalMarkets #EconomicDevelopment

From January to September 2024, China exported over 870 key pharmaceutical intermediates to India, with a total transaction value exceeding USD 1.75 billion. The top 30 products alone accounted for over USD 1.154 billion, reflecting a year-on-year decrease of 1.97%. Among these, 14 products saw a decline in transaction value, with the largest drop exceeding 50%, while the transaction value of 16 products increased year-on-year. The long-standing top product, 6-APA, had a transaction value of over USD 380 million. Additionally, five products recorded transaction values exceeding USD 50 million, and 20 products exceeded USD 10 million. Among the top 30 intermediate products, the transaction value of the Remimazolam intermediate (CAS 1289024-42-5) grew the fastest, increasing by over 317 times year-on-year, with quantities rising from kilogram-level to a 2-ton scale. #Intermediates #APIs #Rawmaterials #Pharma #Pharmaceuticalingredients

*Pakistan's Pharmaceutical Exports Soar: 31.11% Growth in Q1 2024-25!* Breaking News! Pakistan's pharmaceutical industry is making waves globally, recording a remarkable 31.11% increase in exports in the first quarter of FY 2024-25! Key Highlights: - $105.936 million in exports from July to September 2024, up from $80.796 million in 2023 - 61.55% year-on-year surge in September 2024, reaching $43.607 million - 53.78% month-on-month growth from August 2024 This impressive growth showcases Pakistan's expanding pharmaceutical capabilities and competitiveness on the global stage! *What's driving this success?* - Increased demand for quality generics - Growing international partnerships - Enhanced manufacturing capabilities - Government support for exports *Congratulations to Pakistan's pharmaceutical industry!* Let's discuss: - What opportunities arise from this growth? - How can we sustain this momentum? - What role can international collaborations play? Share your insights! #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation #GrowthStory #IndustryNews #TradeNews #BusinessUpdate #MarketWatch #Trends2024 #BusinessInsights #HealthcareSector #PakistanEconomy #ExportLedGrowth #PharmaceuticalManufacturing

Amid the complex challenges facing the global economy and a slight weakening in growth momentum, the global pharmaceutical market has seen a slowdown in growth. However, the vitality of research and innovation remains strong, indicating profound changes within the industry and sustained development potential. Meanwhile, the ongoing expansion of the generic drug market provides growth opportunities for China's pharmaceutical import and export trade. Various major global markets have adopted different policy measures to reduce prices and control costs, improving drug accessibility. At the same time, the continuous updating and improvement of regulatory policies have placed higher demands on the quality and market adaptability of imported drugs. China's pharmaceutical import and export data reveals new trends in industry development: In the first half of 2024, the total import and export value of pharmaceuticals reached $52.96 billion, representing a 2.5% decline compared to the same period last year. However, this decrease is noticeably smaller than in previous periods, indicating that the market is gradually stabilizing. Of this total, exports amounted to $26.97 billion, a year-on-year increase of 2.0%, while imports totaled $25.99 billion, a year-on-year decrease of 6.8%. #APIs #Rawmaterials #Pharma #Medicine #Pharmaceutical

Can India Reclaim API Throne from China? Despite having the third-largest #pharmaceuticalindustry by volume in the world and being the largest manufacturer of #genericmedicines globally, India is heavily dependent on China for imports of raw materials, Key Starting Materials (KSMs), and Active Pharmaceutical Ingredients (APIs). The plan to make APIs in India has been in the works for some time but the Council of Scientific and Industrial Research (CSIR) was engaged only recently. Let’s see how these steps taken by the government help to promote the production of KSMs and APIs in India in the coming years. Manbeena Chawla Ph.D. Shivani Thakar Manasee Kurlekar Biotechnology Industry Research Assistance Council (BIRAC) Lupin Pfizer Novartis Viatris #APIindustry #biopharmaindustry #MarketResearch #pharmaceuticalmanufacturers https://lnkd.in/dTtTi37X

In my latest article published in the Daily Observer, I explore both the promising prospects and the current challenges shaping the future of the Pharmaceutical sector. Read the full article to discover the key factors driving this transformation. https://lnkd.in/g5-THVHD

India's pharma exports rise 10% to USD 27.9 bn in FY24 Experts have said that India's pharmaceutical business may exceed USD 130 billion by 2030, supported by expanding market opportunities and heightened demand in the overseas markets. The business stood at over USD 50 billion for the 2022-23. #IndiasPharmaExports | #IndiaPharmaceuticalBuisness | #Overseasmarket | #MarketOpportunities | #Healthnews Read more: